Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Home Control International Limited ( (HK:1747) ) just unveiled an update.
Home Control International Limited has established a wholly-owned subsidiary, Orbiva Limited, in Hong Kong to spearhead its strategic expansion into the healthcare sector. This move is part of the company’s broader strategy to develop an AIoT-enabled home healthcare platform and ecosystem, integrating hardware, software, data, and services. Orbiva Limited will focus on creating intelligent healthcare products and services, aiming to build a comprehensive digital health management system. The company is also exploring partnerships with universities and fintech institutions to enhance its technological and operational capabilities.
The most recent analyst rating on (HK:1747) stock is a Hold with a HK$4.50 price target. To see the full list of analyst forecasts on Home Control International Limited stock, see the HK:1747 Stock Forecast page.
More about Home Control International Limited
Home Control International Limited operates in the technology industry, focusing on IoT and smart remote control solutions. The company has expanded its market focus to include healthcare solutions, leveraging its technological expertise to design, manufacture, and sell products, particularly in the hearing-aid accessory category.
Average Trading Volume: 2,033,383
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.06B
Find detailed analytics on 1747 stock on TipRanks’ Stock Analysis page.